CTCF promotes colorectal cancer cell proliferation and chemotherapy resistance to 5-FU via the P53-Hedgehog axis.

Aging
Qiuhua LaiSide Liu

Abstract

CTCF is overexpressed in several cancers and plays crucial roles in regulating aggressiveness, but little is known about whether CTCF drives colorectal cancer progression. Here, we identified a tumor-promoting role for CTCF in colorectal cancer. Our study demonstrated that CTCF was upregulated in colorectal cancer specimens compared with adjacent noncancerous colorectal tissues. The overexpression of CTCF promoted colorectal cancer cell proliferation and tumor growth, while the opposite effects were observed in CTCF knockdown cells. Increased GLI1, Shh, PTCH1, and PTCH2 levels were observed in CTCF-overexpressing cells using western blot analyses. CCK-8 and apoptosis assays revealed that 5-fluorouracil chemosensitivity was negatively associated with CTCF expression. Furthermore, we identified that P53 is a direct transcriptional target gene of CTCF in colorectal cancer. Western blot and nuclear extract assays showed that inhibition of P53 can counteract Hedgehog signaling pathway repression induced by CTCF knockdown. In conclusion, we uncovered a crucial role for CTCF regulation that possibly involves the P53-Hedgehog axis and highlighted the clinical utility of colorectal cancer-specific potential therapeutic target as disease...Continue Reading

References

Dec 18, 2001·Science·Wendy ChaoJeannie T Lee
Jun 4, 2004·The New England Journal of Medicine·David G PfisterMark R Somerfield
Feb 4, 2005·The New England Journal of Medicine·Jeffrey A Meyerhardt, Robert J Mayer
Jul 1, 2005·The New England Journal of Medicine·Carmen Allegra, Daniel J Sargent
Mar 11, 2008·Lancet·Henrik Kehlet
Aug 28, 2012·International Journal of Oncology·Feng-Ting HuangShi-Neng Zhang
May 8, 2013·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·Sjoerd Johannes Bastiaan Holwerda, Wouter de Laat
Nov 1, 2013·International Journal of Cancer. Journal International Du Cancer·Vegard EldholmShanbeh Zienolddiny
Nov 15, 2013·Lancet·Hermann BrennerChristian Peter Pox
Oct 10, 2014·The Journal of Biological Chemistry·Jon H ChungFred Bunz
Jun 6, 2015·Experimental & Molecular Medicine·Somi KimBong-Kiun Kaang
Apr 9, 2016·Cell·Loredana VecchioneRené Bernards
May 6, 2016·Annual Review of Biochemistry·Andreas C Joerger, Alan R Fersht
Oct 21, 2016·Cell Reports·Marios GiannakisLevi A Garraway
Jan 12, 2017·The New England Journal of Medicine·John M Inadomi
Mar 2, 2017·CA: a Cancer Journal for Clinicians·Rebecca L SiegelAhmedin Jemal
Jun 27, 2017·BMB Reports·Sumin OhKyung Hyun Yoo
Aug 19, 2017·Journal of Cancer·Ji-Yeon LeeMyoung Hee Kim
Nov 22, 2017·International Journal of Biological Macromolecules·Xiaoqin YuYang Qin
Jan 9, 2018·Genomics & Informatics·Sang-Hyun Song, Tae-You Kim
Sep 22, 2018·International Journal of Molecular Sciences·Etienne Giroux-LeprieurBiao He
Jan 15, 2019·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Ali SalaritabarSamira Shirooie
Aug 3, 2019·Journal of Experimental & Clinical Cancer Research : CR·Qingyuan LiSide Liu

❮ Previous
Next ❯

Methods Mentioned

BETA
immunoprecipitation
flow cytometry
ChIP-PCR
ChIP
FACS
PCR

Software Mentioned

GSEA
Gene Expression Profiling Interactive Analysis ( GEPIA
STICH
SPSS
PubChem
GEPIA
SuperPred Target - Prediction

Related Concepts

Related Feeds

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Aging Genetics (Keystone)

This feed focuses on aging epidemiology and genetic, epigenetic, and proteomic aspects underlying aging, as well as aging- associated biomarkers. Here the latest research in this domain.